Clinical Trials Directory

Trials / Completed

CompletedNCT05881252

Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

An Observational Study of Perinatal Outcomes Following Change in Clinical Criteria in for Treatment of Maternal Hypertension

Status
Completed
Phase
Study type
Observational
Enrollment
1,003 (actual)
Sponsor
The University of Texas Health Science Center, Houston · Academic / Other
Sex
Female
Age
Healthy volunteers
Not accepted

Summary

The purpose of this study is observe outcomes before and after a change in clinical practice in the threshold for management of severe hypertension in pregnancy and the post-partum period. Outcomes will be observed for 10 months under the current (traditional) clinical blood pressure threshold for acute treatment of hypertension, which is \>= 160 millimeters of mercury (mmHg) systolic blood pressure (SBP). This will be followed by one month of education about rationale for the new SBP threshold of \>= 180 mmHg and change of clinical guidelines. Then, there will be 10 months of observation after adopting the updated clinical threshold for acute antihypertensive treatment (\>= 180 SBP).

Conditions

Interventions

TypeNameDescription
PROCEDUREClinical blood pressure threshold of SBP >= 160 mmHg for acute treatment of hypertensionPatients are treated for hypertension if SBP \>= 160 mmHg.
PROCEDUREClinical blood pressure threshold of SBP >= 180 mmHg for acute treatment of hypertensionPatients are treated for hypertension if SBP \>= 180 mmHg.

Timeline

Start date
2023-05-11
Primary completion
2024-04-04
Completion
2024-04-04
First posted
2023-05-31
Last updated
2025-07-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05881252. Inclusion in this directory is not an endorsement.